Cargando…
miR‐181a/b downregulation exerts a protective action on mitochondrial disease models
Mitochondrial diseases (MDs) are a heterogeneous group of devastating and often fatal disorders due to defective oxidative phosphorylation. Despite the recent advances in mitochondrial medicine, effective therapies are still not available for these conditions. Here, we demonstrate that the microRNAs...
Autores principales: | Indrieri, Alessia, Carrella, Sabrina, Romano, Alessia, Spaziano, Alessandra, Marrocco, Elena, Fernandez‐Vizarra, Erika, Barbato, Sara, Pizzo, Mariateresa, Ezhova, Yulia, Golia, Francesca M, Ciampi, Ludovica, Tammaro, Roberta, Henao‐Mejia, Jorge, Williams, Adam, Flavell, Richard A, De Leonibus, Elvira, Zeviani, Massimo, Surace, Enrico M, Banfi, Sandro, Franco, Brunella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505685/ https://www.ncbi.nlm.nih.gov/pubmed/30979712 http://dx.doi.org/10.15252/emmm.201708734 |
Ejemplares similares
-
miR‐181a/b downregulation: a mutation‐independent therapeutic approach for inherited retinal diseases
por: Carrella, Sabrina, et al.
Publicado: (2022) -
The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer
por: Indrieri, Alessia, et al.
Publicado: (2020) -
Mutation-Independent Therapies for Retinal Diseases: Focus on Gene-Based Approaches
por: Carrella, Sabrina, et al.
Publicado: (2020) -
Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
por: Indrieri, Alessia, et al.
Publicado: (2020) -
Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma
por: Barbato, Anna, et al.
Publicado: (2021)